Total Payments
$1,502
2023 Payments
$258.01
Companies
9
Transactions
24
Medicare Patients
806
Medicare Billing
$79,345
Payment Breakdown by Category
Food & Beverage$1,502 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,502 | 24 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $657.42 | 11 | $0 (2023) |
| Alexion Pharmaceuticals, Inc. | $206.14 | 2 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $151.89 | 5 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $109.02 | 1 | $0 (2022) |
| Merck Sharp & Dohme LLC | $100.21 | 1 | $0 (2023) |
| CSL Behring | $97.76 | 1 | $0 (2023) |
| BTG INTERNATIONAL, INC. | $89.32 | 1 | $0 (2020) |
| La Jolla Pharmaceutical Company | $78.56 | 1 | $0 (2020) |
| Actelion Pharmaceuticals US, Inc. | $11.20 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $258.01 | 5 | Merck Sharp & Dohme LLC ($100.21) |
| 2022 | $603.97 | 7 | AstraZeneca Pharmaceuticals LP ($329.92) |
| 2021 | $300.72 | 7 | AstraZeneca Pharmaceuticals LP ($162.80) |
| 2020 | $232.88 | 4 | BTG INTERNATIONAL, INC. ($89.32) |
| 2019 | $105.94 | 1 | AstraZeneca Pharmaceuticals LP ($105.94) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/09/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.22 | General |
| Category: Cardiovascular | ||||||
| 06/01/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: Rare Disease | ||||||
| 04/13/2023 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $97.76 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 02/18/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: Rare Disease | ||||||
| 01/12/2023 | Merck Sharp & Dohme LLC | RECARBRIO (Drug) | Food and Beverage | In-kind items and services | $100.21 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/10/2022 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $109.55 | General |
| Category: Rare Disease | ||||||
| 10/13/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $97.91 | General |
| Category: Rare Disease | ||||||
| 09/08/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $55.92 | General |
| Category: Cardiovascular | ||||||
| 07/14/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $109.02 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/14/2022 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $112.18 | General |
| Category: Rare Disease | ||||||
| 04/08/2022 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: Cardiology | ||||||
| 03/10/2022 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $108.19 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/22/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/16/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/09/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/08/2021 | Alexion Pharmaceuticals, Inc. | Andexxa (Drug) | Food and Beverage | In-kind items and services | $108.23 | General |
| Category: Hematology | ||||||
| 05/15/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.99 | General |
| Category: Cardiovascular | ||||||
| 05/13/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $118.27 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/01/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.70 | General |
| Category: Cardiovascular | ||||||
| 05/26/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/12/2020 | BTG INTERNATIONAL, INC. | CROFAB (Drug) | Food and Beverage | Cash or cash equivalent | $89.32 | General |
| Category: ANTI-VENOM | ||||||
| 02/13/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $52.06 | General |
| Category: Cardiovascular | ||||||
| 01/09/2020 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $78.56 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 09/12/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $105.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 471 | 489 | $426,111 | $40,809 |
| 2022 | 4 | 262 | 267 | $179,209 | $29,076 |
| 2021 | 2 | 73 | 73 | $46,099 | $9,460 |
Total Patients
806
Total Services
829
Medicare Billing
$79,345
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 235 | 242 | $330,971 | $31,882 | 9.6% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 78 | 79 | $73,642 | $7,170 | 9.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 143 | 153 | $12,240 | $937.89 | 7.7% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 15 | 15 | $9,258 | $818.55 | 8.8% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 165 | 168 | $139,265 | $22,931 | 16.5% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 51 | 51 | $29,577 | $4,664 | 15.8% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 24 | 24 | $8,495 | $1,331 | 15.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 22 | 24 | $1,872 | $150.00 | 8.0% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 52 | 52 | $36,162 | $7,452 | 20.6% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 21 | 21 | $9,937 | $2,009 | 20.2% |
About Dr. Dillon Pryor, DO
Dr. Dillon Pryor, DO is a Emergency Medicine healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/29/2019. The National Provider Identifier (NPI) number assigned to this provider is 1316501992.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dillon Pryor, DO has received a total of $1,502 in payments from pharmaceutical and medical device companies, with $258.01 received in 2023. These payments were reported across 24 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($1,502).
As a Medicare-enrolled provider, Pryor has provided services to 806 Medicare beneficiaries, totaling 829 services with total Medicare billing of $79,345. Data is available for 3 years (2021–2023), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Location Oklahoma City, OK
- Active Since 04/29/2019
- Last Updated 09/01/2020
- Taxonomy Code 207P00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1316501992
Products in Payments
- LOKELMA (Drug) $389.87
- ANDEXXA (Biological) $267.55
- ELIQUIS (Drug) $151.89
- XARELTO (Drug) $109.02
- Andexxa (Drug) $108.23
- RECARBRIO (Drug) $100.21
- ULTOMIRIS (Biological) $97.91
- Kcentra (Biological) $97.76
- CROFAB (Drug) $89.32
- GIAPREZA (Drug) $78.56
- OPSUMIT (Drug) $11.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Oklahoma City
Alexander Frank, M.d, M.D
Emergency Medicine — Payments: $3.1M
Emergency Medicine $3.1M
Mohammad Razaq, M.d, M.D
Emergency Medicine — Payments: $177,813
Emergency Medicine $177,813
Jose Borrego Acosta, Md, MD
Emergency Medicine — Payments: $76,213
Emergency Medicine $76,213
Lindsey Epperson
Emergency Medicine — Payments: $36,931
Emergency Medicine $36,931
Dr. Tyson Quy, M.d, M.D
Emergency Medicine — Payments: $35,983
Emergency Medicine $35,983
Michael Partin, M.d, M.D
Emergency Medicine — Payments: $10,117
Emergency Medicine $10,117